The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 05, 2019

Filed:

Feb. 23, 2017
Applicant:

Government of the United States, As Represented BY the Secretary of the Air Force, Wright-Patterson AFB, OH (US);

Inventors:

Joseph M. Slocik, Dayton, OH (US);

Rajesh R. Naik, Centerville, OH (US);

Patrick B. Dennis, Cincinnati, OH (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/44 (2006.01); A61K 39/395 (2006.01); A61K 47/68 (2017.01); C07K 1/10 (2006.01); C07K 1/36 (2006.01); G01N 33/531 (2006.01); C07K 16/00 (2006.01); C07K 16/34 (2006.01); A61K 47/48 (2006.01); C08G 65/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39591 (2013.01); A61K 39/3955 (2013.01); A61K 47/48215 (2013.01); C07K 1/10 (2013.01); C07K 1/36 (2013.01); C07K 16/00 (2013.01); C07K 16/34 (2013.01); C08G 65/00 (2013.01); G01N 33/531 (2013.01);
Abstract

A method for creating a stable protein/antibody ionic liquid, comprising: (a) cationizing aqueous proteins/antibodies by addition of an excess of a positively-charged crosslinker in the presence of a coupling reagent; (b) purifying the cationized proteins/antibodies; (c) titrating the cationized proteins/antibodies with a corresponding biologically-compatible counter anionic polymer to create at least one protein/antibody cation/anion pair in aqueous solution until the cation/anion pair solution becomes negative by zeta potential measurement; (d) repeatedly dialyzing the protein/antibody cation/anion pair in water to remove excess anionic polymer using at least one molecular weight cutoff 7000 dialysis membrane; (e) lyophilizing the protein/antibody cation/anion pair to remove most of the water, forming a lyophilized solid; and (f) heating the lyophilized solid until a protein/antibody ionic liquid is generated. The antibody may be any desired antibody, and the anion may be any biologically-compatible anion.


Find Patent Forward Citations

Loading…